drugset / Trial / NCT00037635
A Study of an Investigational Medication for the Treatment of Secondary Hyperparathyroidism in Dialysis Patients
RandomizedParallel-groupTriple-blindTreatment
Summary
This 6 month long study will assess an investigational medication for patients on dialysis with secondary hyperparathyroidism. The study will look at the effects on parathyroid hormone, calcium and phosphorus levels.
Timeline
- Start
- 2001-12
- Primary completion
- 2003-03
- Completion
- 2003-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cinacalcet | Other / unclassified | 30 mg | Oral |
| Subject | Cinacalcet | Other / unclassified | 60 mg | Oral |
| Subject | Cinacalcet | Other / unclassified | 90 mg | Oral |
| Subject | Cinacalcet | Other / unclassified | 120 mg | Oral |
| Subject | Cinacalcet | Other / unclassified | 180 mg | Oral |